Cargando…
Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol
SIMPLE SUMMARY: The major challenge in pediatric oncology is the optimal adaptation of therapy burden to risk profile, aiming to achieve the best outcome with minimum toxicities. The CWS-2002P study in patients ≤ 21 years with localized rhabdomyosarcoma was developed with this goal by reducing or in...
Autores principales: | Koscielniak, Ewa, Blank, Bernd, Vokuhl, Christian, Kazanowska, Bernarda, Ladenstein, Ruth, Niggli, Felix, Ljungman, Gustaf, Handgretinger, Rupert, Seitz, Guido, Fuchs, Jörg, Fröhlich, Birgit, Scheer, Monika, Wessalowski, Rüdiger, Schmid, Irene, Sparber-Sauer, Monika, Klingebiel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870315/ https://www.ncbi.nlm.nih.gov/pubmed/35205646 http://dx.doi.org/10.3390/cancers14040899 |
Ejemplares similares
-
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials
por: Tramsen, Lars, et al.
Publicado: (2023) -
Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)
por: Urla, Cristian, et al.
Publicado: (2019) -
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
por: Scheer, Monika, et al.
Publicado: (2019) -
The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents
por: Scheer, Monika, et al.
Publicado: (2021) -
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
por: Schober, Sebastian Johannes, et al.
Publicado: (2022)